SAN FRANCISCO — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced it has reached a settlement agreement with Agilent Technologies to resolve all claims and counterclaims in the trade secret litigation filed by Agilent on February 3, 2016. Under […]
A fully automated, high throughput rapid pathogen detection platform is scheduled for market release in April 2020 Crystal Diagnostics (CDx) announced today that the US Patent and Trademark Office (USPTO) issued the company a second patent related to proprietary liquid crystal technology for rapid and accurate detection of foodborne pathogens. The Notice of Allowance complements […]
TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced it has received notification of validation of European patent number EP 3356554 for its methods for subtyping diffuse large B-cell lymphoma (DLBCL), effective October 2019. HTG was previously granted a patent for this […]
VERSAILLES, France — ALGENTECH, announces the issuance of a key patent in the field of genome editing by the U.S. Patent Office (U.S. patent number 10457950). The technology claimed by the patent amplifies the effectiveness of gene editing in eukaryotic cells and can be applied in synergy with nucleases, including zinc finger nucleases, TALENs, Crispr-Cas9… Algentech’s […]
MGI makes the following statement in response to Illumina’s patent litigation in the UK and Sweden: We believe these claims have no merit and are typical Illumina tactics intended to maintain a monopolistic market position and prevent choice from being offered to customers. We intend to vigorously defend ourselves, as we have in other jurisdictions. […]
SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today announced that it has filed two additional patent infringement suits relating to BGI’s sequencing products, including the DNBSeq-400 (also known as MGISeq-2000), DNBSeq-T7, and related chemistry reagents. The first complaint was filed against MGI Tech Co., Ltd. and Latvia MGI Tech SIA in the High Court of […]
Advancements Expected to Accelerate Development of mRNA Therapeutics SAN DIEGO – TriLink BioTechnologies, a Maravai LifeSciences company and a leader in the production of nucleic acids such as DNA and RNA, announced today that the United States Patent and Trademark Office has issued two new patents to the company. Both patents cover advancements in TriLink’s […]
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that the International Trade Commission (ITC) affirmed the Administrative Law Judge’s finding that 10X Genomics infringed three of Bio-Rad’s patents. The Commission also issued a Limited Exclusion Order and Cease and Desist Order against 10X […]
Gives scientists a new view into natural cell activity, accelerating drug development MilliporeSigma, a leader in genome editing, today announced that it has signed a license agreement providing Promega Corp., a global life science manufacturer based in Madison, Wisconsin, access to MilliporeSigma’s foundational CRISPR intellectual property. Promega will use MilliporeSigma’s CRISPR genome-editing technology to create research products […]
Scientists will have new view into natural cell activity, accelerating drug development Madison, WI USA. Promega Corporation today announced it has signed a license agreement with MilliporeSigma, a leader in genome editing, to access MilliporeSigma’s foundational CRISPR genome-editing technology. Under the agreement, Promega will create new research products for investigating endogenous biology, including those for drug […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
